We are live on ! Find out more
PRTC

PureTech Health
PRTC

Delisted

PRTC was delisted on the 20th of May, 2026.

Back to rankings

4 hedge funds and large institutions have $3.98M invested in PureTech Health in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more capital invested

Capital invested by funds: $1.47M → $3.98M (+$2.5M)

100% more funds holding

Funds holding: 2 → 4 (+2)

0.02% more ownership

Funds ownership: 0.01% → 0.03% (+0.02%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PCM
Portolan Capital Management
Massachusetts
+$2.55M
2
MIFH
Migdal Insurance & Financial Holdings
Israel
+$18.1K

Top Sellers

1
UBS Group
UBS Group
Switzerland
-$2.09K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
1
Portolan Capital Management
Massachusetts
$2.52M +$2.55M +52,421 New
AIC
2
AWM Investment Company
New York
$1.44M – – –
MIFH
3
Migdal Insurance & Financial Holdings
Israel
$18K +$18.1K +373 New
UBS Group
4
UBS Group
Switzerland
$1K -$2.09K -43 -68%

PRTC Hedge Fund Activity: Q3 2021 in Review

4 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q3 2021, worth a combined $3.98M — up 170% from $1.47M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PRTC positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Portolan Capital Management, opening a new position worth an estimated $2.55M. The largest seller was UBS Group, cutting an estimated $2.09K.

  • 4 institutional investors held PureTech Health (PRTC) as of Q3 2021, up from 2 in Q2 2021.
  • Funds reported $3.98M of PureTech Health stock for Q3 2021, up 170% quarter-over-quarter.
  • 2 funds opened new PureTech Health positions in Q3 2021 and 0 closed out, a net change of +2 holders.
  • The largest PureTech Health buyer in Q3 2021 was Portolan Capital Management, an estimated $2.55M added.
  • The largest PureTech Health seller in Q3 2021 was UBS Group, an estimated $2.09K sold.

Based on aggregated 13F filings for Q3 2021.